TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Dysphagia scoring for liquids at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia scoring for solid food at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life post-surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: alcohol outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy for performing activities in spite of pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: catecholamine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: frequency of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need to supplement the surgery with local anesthetic
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: amount of local anesthetic used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Phagocytic activity of granulocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinical outcome improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance and maintenance of health behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capacity (NYHA Class)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EQ‐5D index scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean adherence based on pill intake recall
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sealer penetration into controlled gaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalizations for cardiac events
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Symptomatic skeletal events
Endpoint domain: Adverse events/effects
Primary endpoint: Leisure-time moderate-to-vigorous physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the Mediterranean diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: occupational performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attempts required to establish venous cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications observed (tinnitus)
Endpoint domain: Adverse events/effects
Primary endpoint: Progression of structural damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease activity and functional disability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of oral greasy-sticky symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of thirsty symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protracted abstinence symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year re-abusing rate
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in fasting insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in OGTT insulin area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in abdominal subcutaneous adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean time to progression of retinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of cytomegalovirus from blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: percent overweight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBV dose reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSF 3-AP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum increase in SCr levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Median pairwise genetic distance between HIV subtype C sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated date of origin of HIV subtype C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median estimated substitution rate among study pol sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat jump height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop jump height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in physical activity behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge about osteoporosis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived susceptibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: taking health action
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: PpIX fluorescence accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean Lp(a) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: timed up-and-go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC index pain subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC index physical function subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of being free of readmissions for heart failure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: dyspnoea sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Concentration of CO groups in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidase activity of Cp
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfer to PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delivery with an intact perineum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of serious or very serious drug interactions
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of prescriptive inappropriateness
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative atrial fibrillation duration
Endpoint domain: Adverse events/effects
Primary endpoint: Improvements in ADHD symptoms relating to hyperactivity and impulsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in daily functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ZBPI ADL burden of interference score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Asymmetric dimethylarginine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrovascular reserve capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Bone mass accrual
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total bacteria reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total coliforms reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total duration of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cumulative incidence of gastric ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative incidence of duodenal ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient and family responsiveness to the program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Residual psychotic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall incidence of postextubation cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude of sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sperm morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of infants with clinical intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Vaginal Maturation Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Time taken to repair the wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress rating by doctors, nurses, and parents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence rate of subsequent diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of toxic tubulopathy
Endpoint domain: Adverse events/effects
Primary endpoint: Acute nephrotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: FVC, FEV1, and PEFR values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: General Health Questionnaire (GHQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective evaluation of nasal obstruction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative cardiovascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraoperative complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: catheter time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of correct answers in the first test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Silver particle penetration percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACBAR of desflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum mean CA-125 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological improvement in gastritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection of extrahepatic malignant disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Influence on clinical management
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: mean percentage hair reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flow-mediated dilation (FMD) post-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal rate due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: 12-month smoking cessation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of stunting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in TEE simulator scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of AH as food/nutrition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of target detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EDV RH-PAT index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: asymmetric dimethylarginine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak systolic radial strain of the posterior wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in BCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of symptomatic exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: Percent decline in tHcy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in first stroke risk
Endpoint domain: Mortality/survival
Primary endpoint: total number of failed attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental workload
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: CD34+ cells count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hib anti-PRP antibody concentrations > or = 1 microg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: reduced visible deposits of endometriosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total subjective symptoms scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: general intelligence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Reaching target HbA1c <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30-day hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Discrimination between indolent and significant disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean peak BrAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cued go/no-go task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: serum total cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: HDL cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Feedback read
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feedback saved
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Personal relevance of feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Angle correction between M-mode and AM-mode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurements of M-mode, AM-mode, and 2DSI compared to TDD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events per subject
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in rectal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 1-minute heart rate recovery (HRR1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2-minute heart rate recovery (HRR2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in resting and movement-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in opioid (morphine) consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: More rapid bowel recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lack of intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of erosive esophagitis diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: progressive disease
Endpoint domain: Mortality/survival
Primary endpoint: NYHA class changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear Film Grade (TF grade)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-Invasive Keratograph Break-Up Time (NIKBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eyes within 1.0 D of targeted correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manifest refraction changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB IRIS occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Counts of pathological gram-negative rods
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acetic acid concentration in the gut
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Counts of Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improved renal function at 1-month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Presence and concentration of infant OVA at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Technical problems during endoscopic insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction with general care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Menstruation resumption rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to menses return after chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rejection-free graft survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Vaccination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: success of premedication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptance of parental separation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: acceptance of face mask for induction of anaesthesia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in 25(OH)D3 levels at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone density measurements <10 percentile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28‐P score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OPA titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Volume at first involuntary detrusor contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of urge episodes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total number of voids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: number of episodes of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of transfusion-acquired CMV infection
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of joint bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean improvement of joint state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ankle joint pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incremental cost-effectiveness ratios
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean plasma levels of 25OHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median parathyroid hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean daytime diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean daytime systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall marginal discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall marginal adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late loss at target lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Binary restenosis rates at target lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Target vessel revascularization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of subsidence
Endpoint domain: Adverse events/effects
Primary endpoint: Solid fusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in disc height and segmental lordotic angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total drusen diameter reduction in the inner subfield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes